Back to Rare Disease
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT00898079

NCT00898079
Completed Not Applicable 🇦🇺 Australian site

Who may be able to join

Who might be able to join this trial:

  • You have been diagnosed with a primary (original) cancer or have developed a second cancer.
  • Your cancer diagnosis falls under specific classification codes used in a standard international cancer coding system (confirm with trial site).
  • You have biological samples available, such as tumor tissue that has been preserved in one of several accepted ways, along with at least 10 unstained laboratory slides prepared from that tissue.
  • If you have a fluid-based cancer sample (such as fluid from around the lungs), at least 1 mL of that fluid and at least 2 prepared slides are available.
  • If you have a type of leukemia (ALL or AML), samples of bone marrow (3–6 mL) and blood (10 mL) are available.
  • If you have a rare tumor type, slides for specialist review are available instead of the standard quality-check slides.
  • You are not currently eligible for another specific cancer biology or tissue banking study.

Who may not be able to join:

  • You do not have the required biological samples (such as tumor tissue, fluid samples, or blood and bone marrow samples) available in the formats specified.
  • You are already eligible for and enrolled in another disease-specific biology or tissue banking research study.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
Children's Oncology Group
Registry
clinicaltrials_gov
Start date
13 October 2003
Est. completion
30 June 2018

Where this trial is recruiting

🇦🇺 Australia 🇨🇦 Canada 🇳🇿 New Zealand Puerto Rico 🇨🇭 Switzerland 🇺🇸 United States

2 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

Repository of malignant, borderline malignant neoplasms, and related biological specimens

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov